BioNTech Stock Covid-19 Manufacturer Buy Opportunity. A strong weekly demand level has been reached as expected. BioNTech Stock price rallying as expected and mentioned in the set and forget trading community.
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to treating diseases. With Pfizer, BioNTech has created one of the most successful covid-19 vaccines, saving millions of lives.
See below at BioNTech stock analysis and forecast. This trade was called a few weeks ago, it’s been only a couple of weeks ago that the stock reached out entry. The stock price has pulled back to the price level around $233 per share, and it’s reacting as expected.
Watch BioNTech forecast on the supply and demand technical analysis below.
As supply and demand traders, we do not need to pay attention to the news, fundamentals or any earnings reports. Once a big timeframe imbalance has gained control, earnings do just the opposite and react strongly to those imbalances. Why is it that you see positive earnings and then the underlying stock drops like a rock, or a negative earnings announcement and the stock rallies like a rocket out of control? You are probably missing the fact that there are big imbalances gaining control.
Unless you are doing very short term trading and scalping, you should not worry about fundamentals or earnings announcements on BioNTech stock.
You can use these imbalances to plan your trades in lower timeframes. Trading is just waiting for the right trigger points and scenarios to present themselves, this game has got a name and it’s called the waiting game. We need to patiently wait for the correct scenarios and setups to happen and wait for the price to pull back or dip into the price levels we want to trade, in our case these price levels are made of supply and demand imbalances.
If you want to learn how to trade using our supply and demand trading strategy, join our supply and demand stock trading course.